Hoffman Sara, Propp Jennifer M, McCarthy Bridget J
Department of Epidemiology, University of Illinois at Chicago, 1603 W. Taylor, M/C 923, Chicago, IL 60612, USA.
Neuro Oncol. 2006 Jan;8(1):27-37. doi: 10.1215/S1522851705000323.
A number of reports have indicated an increasing incidence of primary brain tumors over the past few decades. The purpose of this study was to describe incidence rate trends in a population-based series of newly diagnosed primary nonmalignant and malignant brain and other CNS tumors, contributing five additional years to previously published incidence trends. Data for the years 1985 through 1999 from six collaborating state cancer registries of the Central Brain Tumor Registry of the United States were used to determine incidence trends in the broad age groups 0-19, 20-64, and >or=65 years, overall and for selected histologies. Multiplicative Poisson regression was used to express trends as average annual percent change (AAPC). Joinpoint regression was used to identify sharp changes in incidence occurring over this period. Overall, incidence increased modestly (AAPC, 1.1; 95% CI, 0.8-1.4). When brain lymphomas were excluded, this increase remained statistically significant. A sharp change in incidence of brain lymphomas from increasing to decreasing over time was identified. Specific histologies that were increasing included anaplastic astrocytomas in individuals aged >or=65 years, microscopically confirmed gliomas in both adult age groups, and microscopically confirmed glioma, not otherwise specified (NOS), in children. Increases that were not specific to any population subgroup were seen for oligodendrogliomas, ependymomas, meningiomas, and nerve sheath tumors. Decreases were noted for astrocytoma, NOS, nonmicroscopically confirmed gliomas, and pituitary tumors. Improvements in diagnosis and classification are likely reflected in the decreasing trends in unspecified glioma subgroups and the accompanying increasing trends in more specific glioma subgroups. However, increases in meningiomas and nerve sheath tumors deserve further attention.
一些报告表明,在过去几十年中,原发性脑肿瘤的发病率呈上升趋势。本研究的目的是描述基于人群的一系列新诊断的原发性非恶性和恶性脑及其他中枢神经系统肿瘤的发病率趋势,在先前公布的发病率趋势基础上再增加五年的数据。利用美国中央脑肿瘤登记处六个合作州癌症登记处1985年至1999年的数据,确定0-19岁、20-64岁和≥65岁这几个广泛年龄组总体以及特定组织学类型的发病率趋势。采用乘性泊松回归将趋势表示为平均年变化百分比(AAPC)。使用连接点回归来识别这一时期发病率的急剧变化。总体而言,发病率适度上升(AAPC为1.1;95%可信区间为0.8-1.4)。排除脑淋巴瘤后,这种上升在统计学上仍具有显著性。确定了脑淋巴瘤发病率随时间从上升变为下降的急剧变化。发病率上升的特定组织学类型包括≥65岁个体的间变性星形细胞瘤、两个成人年龄组显微镜确诊的胶质瘤以及儿童显微镜确诊的未另行指定(NOS)的胶质瘤。少突胶质细胞瘤、室管膜瘤、脑膜瘤和神经鞘瘤在所有人群亚组中均有上升,但无特异性。星形细胞瘤NOS、非显微镜确诊的胶质瘤和垂体瘤发病率下降。诊断和分类的改善可能反映在未指定胶质瘤亚组的下降趋势以及更特定胶质瘤亚组随之上升的趋势中。然而,脑膜瘤和神经鞘瘤的增加值得进一步关注。